PAMG
Patton Albertson Miller Group’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-17,767
| Closed | -$892K | – | 132 |
|
|
2016
Q2 | $892K | Sell |
17,767
-9,218
| -34% | -$463K | 0.4% | 68 |
|
|
2016
Q1 | $1.44M | Sell |
26,985
-919
| -3% | -$49.2K | 0.73% | 47 |
|
|
2015
Q4 | $1.83M | Sell |
27,904
-37
| -0.1% | -$2.43K | 0.92% | 37 |
|
|
2015
Q3 | $1.58M | Sell |
27,941
-7,387
| -21% | -$417K | 0.84% | 42 |
|
|
2015
Q2 | $2.09M | Sell |
35,328
-12
| -0% | -$709 | 0.91% | 48 |
|
|
2015
Q1 | $2.2M | Buy |
35,340
+6,075
| +21% | +$379K | 0.89% | 49 |
|
|
2014
Q4 | $1.68M | Buy |
29,265
+11,433
| +64% | +$658K | 0.78% | 48 |
|
|
2014
Q3 | $955K | Buy |
17,832
+7,581
| +74% | +$406K | 0.5% | 77 |
|
|
2014
Q2 | $542K | Buy |
10,251
+566
| +6% | +$29.9K | 0.27% | 111 |
|
|
2014
Q1 | $512K | Sell |
9,685
-1,935
| -17% | -$102K | 0.27% | 94 |
|
|
2013
Q4 | $466K | Buy |
11,620
+3,395
| +41% | +$136K | 0.27% | 88 |
|
|
2013
Q3 | $311K | Buy |
+8,225
| New | +$311K | 0.18% | 101 |
|